8:15-8:30 |
Welcome and Introductions |
8:30-9:00 |
Overview of the Bioelectronic Medicine Industry James Cavuoto, Editor, Neurotech Reports
BioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including recent events, key players, technological roots, and market projections. |
9:00-9:30 |
Keynote Address
Michel Maharbiz, Ph.D., CEO, iota Biosciences
A bioelectronic medicine industry executive and longtime industry observer offers their views on what lies ahead. |
9:30-10:15 |
Bioelectronic Medicine ROI
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Allan Gobbs, Co-Founder and Managing Partner, ATEM Capital
Jeff Chu, Managing Partner, Features Capital
Several recent high-profile exits and investment deals have raised the stakes for enterpreneurs and investors alike. In this session, venture capital professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine. |
10:15-10:45 |
Refreshment Break |
10:45-11:30 |
Entrepreneur Panel I
James Cavuoto, Editor, Neurotech Reports, Moderator
Ben Woodington, Ph.D., CEO, Coherence Neuro
Miguel Vilaplana, MD, CEO, Graphenicalab SL
Presentations from executives of emerging bioelectronic medicine firms. |
11:30-12:15 |
Novel Diagnostics Drive New Therapies
James Cavuoto, Editor, Neurotech Reports, Moderator
Nandan Lad, M.D., Ph.D., Professor of Neurosurgery, Duke University
Marom Bikson, Ph.D., Professor of Biomedical Engineering, CCNY
Kiran Patel, M.D., Founder and CEO, NYC Neuromodulation Center of Excellence
Advances in bioelectronic medicine have come not only from identifying new neuromodulation targets, but also from integrating novel biological signals into the therapeutic regimen. In this session, experienced investigators and entrepreneurs will offer their thoughts on how new thinking in bioelectronic medicine can yield new opportunities for life science firms.
|
12:15-1:15 |
Luncheon
|
1:15-1:30 |
Luncheon Speaker
|
1:30-2:15 |
Clearing the Market for Respiratory Disorders
Victor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report, Moderator
Jay Jiang, Ph.D., CTO, Spiro Medical
The market for treating respiratory disorders such as asthma and obstructive sleep apnea is one of the most promising segments of the bioelectronic medicine industry. In this session, we'll look at the competitive outlook and opportunities for innovation. |
2:15-3:00 |
Entrepreneur Panel II
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Mehmet Gunal, Ph.D., CEO, Brill Neurotech
Presentations from executives of emerging bioelectronic medicine firms. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
Emerging Market Segments
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Jeffrey Cohen, Director of Research, Ladenburg Thalmann
In this session, we'll look at some of the new opportunities awaiting investors in the space. |
4:15-5:00 |
A Fireside Chat
James Cavuoto, Editor, Neurotech Reports, Moderator
Jennifer French, Executive Director, Neurotech Network
Neurotech Reports editors chat with a key figure from the bioelectronic medicine industry.
|
5:00-6:30 |
Cocktail Reception
|
|
|